arrow
Return

Quantitative Impurity Rejection Analysis for Crystallization

delete2018-05-28
delete10
PRE
AI
D
Daniel D. Caspi *
F
Fredrik L. Nordström
DOI:10.1021/acs.oprd.8b00143delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The analysis of impurity profiles is one of the most frequently performed activities in drug development. While mass-based quantification using a reference standard often provides the highest degree of accuracy, carrying this out on every impurity across the synthetic scheme can quickly become untenable when considering the often large number of impurities and the requirement for a synthesized and characterized reference standard. These labor-intensive activities are generally reserved for only selected impurities using a science- and risk-based approach, and approximations such as purge factor or before and after peak area % are often used in the remaining cases when a wider margin of error is acceptable. Presented herein is a simple mathematical framework to perform mass-based quantification for impurity rejection in silico using the principles of mass balance without the burdensome requirements of obtaining individual response factors or reference standards. This analysis is expected to provide useful guidance for process and analytical chemists.
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

O
Organic Process Research and Development
IF:
3.5
Papers:
5.8K
Citations:
1.1W

Organization

B
Boehringer Ingelheim
Scholars:
6.8K
Papers: 3.9K
Citations: 18
A
AbbVie
Scholars:
7.5K
Papers: 3.8K
Citations: 23
Cited Papers

Cited Papers

Assessing mass balance in pharmaceutical drug products: New insights into an old topic
err2013-09-01
err14
PREAI
errBaertschi, Steven W.; Pack, Brian W.; Hyzer, Cherokee S. Hoaglund; Nussbaum, Mark A.
errShare
errSave
A Kinetics-Based Approach for the Assignment of Reactivity Purge Factors
err2015-10-20
err6
PREAI
errBetori, Rick C.; Kallemeyn, Jeffrey M.; Welch, Dennie S.
errShare
errSave
Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control
err2013-02-04
err108
PREAI
errTeasdale, Andrew; Elder, David; Chang, Sou-Jen; Wang, Sophie; Thompson, Richard; Benz, Nancy; Flores, Ignacio H. Sanchez
errShare
errSave